characteristics.text: SAMD00239465
characteristics.characteristic: External Id
characteristics.text: Drug Discovery Research Group, Research and Development Division, Biofermin Pharmaceutical Co., Ltd.
characteristics.characteristic: INSDC center name
characteristics.text: 2022-07-30T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-06-02T05:00:02.197Z
characteristics.characteristic: INSDC last update
characteristics.text: DRS247598
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: MIMS.me.human-gut
characteristics.characteristic: NCBI submission model
characteristics.text: MIMS.me.human-gut.6.0
characteristics.characteristic: NCBI submission package
characteristics.text: DRS247598
characteristics.characteristic: SRA accession
characteristics.text: 2019-06-14
characteristics.characteristic: collection date
characteristics.text: Keywords: GSC:MIxS;MIMS:6.0
characteristics.characteristic: description
characteristics.text: not appicable
characteristics.characteristic: env_broad_scale
characteristics.text: not appicable
characteristics.characteristic: env_local_scale
characteristics.text: feces
characteristics.characteristic: env_medium
characteristics.text: Japan
characteristics.characteristic: geo loc name
characteristics.text: Homo sapiens
characteristics.characteristic: host
characteristics.text: human gut metagenome
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_408170
characteristics.characteristic: organism
characteristics.text: a-Glucosidase inhibitors and gut microbiome
characteristics.characteristic: project name
characteristics.text: A7-4
characteristics.characteristic: sample name
characteristics.text: Feces of T2D patient (A7) 4 weeks after administration of acarbose
characteristics.characteristic: title